Estetrol/Drospirenone (Nextstellis) – A New Combination Oral Contraceptive
Date: June 28, 2021 Issue #: 1627 Summary: The FDA has approved a combination oral contraceptive containing the estrogen estetrol and the progestin drospirenone (Nextstellis – Mithra/Mayne). Estetrol is the first new estrogen to become available in the US in 50 years. Drospirenone is available alone (Slynd) and in combinations with the estrogen ethinyl estradiol […]